Inventor · disambiguated record
Irene Ghobrial
Also filed as: GHOBRIAL IRENE · GHOBRIAL IRENE M
6 granted patents·9 pending applications·9 citations·filing 2008–2025
73Inventor score
Files withDANA FARBER CANCER INST INC9BRISTOL MYERS SQUIBB CO2MASSACHUSETTS INST TECHNOLOGY2BROAD INST INC1GHOBRIAL IRENE1
Top patents by PatentIndex Score
15 records- 0179US8394816B2Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating Waldenstrom's MacroglobulinemiaGHOBRIAL IRENE·Filed 2008·Granted Mar 12, 2013·5 cites·38 claims
- 0275US10233248B2Treatment of C1013G/CXCR4-associated waldenstroöm's macroglobulinemia with an anti-CXCR4 antibodyBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Mar 19, 2019·2 cites·27 claims
- 0374US9944991B2Compositions and methods for diagnosis, prognosis and treatment of hematological malignanciesDANA FARBER CANCER INST INC·Filed 2013·Granted Apr 17, 2018·2 cites·10 claims
- 0464US2022064738A1Genetic abnormalities in plasma cell dyscrasiasDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 0562US2025189529A1High risk biomarkers for myeloma precursor disease progression and methods of use thereofDANA FARBER CANCER INST INC·Filed 2024·Application pending·0 cites
- 0661US2025285767A1Assessing risk for multiple myeloma precursor disease progressionBROAD INST INC·Filed 2025·Application pending·0 cites
- 0758US11220548B2Treatment of C1013G/CXCR4-associated Waldenstrom's macroglobulinemia with an anti-CXCR4 antibodyBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jan 11, 2022·0 cites·23 claims
- 0858US2025129431A1Methods for characterization of circulating tumor cellsDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 0957US2025299796A1Compositions and methods for treating and/or characterizing hematological malignancies and precursor conditionsDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 1056US11124838B2Genetic abnormalities in plasma cell dyscrasiasDANA FARBER CANCER INST INC·Filed 2016·Granted Sep 21, 2021·0 cites·4 claims
- 1151US12042513B2Proteolysis targeting chimeric molecules (PROTACs) with functional handles and uses thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2020·Granted Jul 23, 2024·0 cites·24 claims
- 1251US2021317143A9Boronic ester prodrugs and uses thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2020·Application pending·0 cites
- 1350US2021087638A1Next-generation sequencing assay for genomic characterization and minimal residual disease detection in the bone marrow, peripheral blood, and urine of multiple myeloma and smoldering myeloma patientsDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 1447US2025297245A1Compositions and methods for single-cell rna sequencingDANA FARBER CANCER INST INC·Filed 2025·Application pending·0 cites
- 1540US2020384130A1B-cell maturation antigen (bcma)-directed nanoparticlesDANA FARBER CANCER INST INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Irene Ghobrial files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →